Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia

Author： O'Neal Catherine S. O'Neal Hollis R. Daniels Titus L. Talbot Thomas R.

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.44, Iss.10, 2012-10, pp. : 726-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Third‐Generation Beta‐Adrenoceptor Antagonists in the Treatment of Hypertension and Heart Failure

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 1, 2015-07 ,pp. : 5-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia

By Kvirikadze N. Suseno M. Vescio T. Kaminer L. Singh K.

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 4, 2006-04 ,pp. : 290-292

Informa Healthcare

Access to resources Recommend Favorite

Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa

By Marais E. Mlambo C. Lewis J. Rastogi N. Zozio T. Grobusch M. Duse A. Victor T. Warren R.

Infection, Vol. 42, Iss. 2, 2014-04 ,pp. : 405-413

Springer Publishing Company

Access to resources Recommend Favorite

Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 114-121

Karger

Access to resources Recommend Favorite

Improved Immunogenicity of a Novel Third-Generation Recombinant Hepatitis B Vaccine in Patients with End-Stage Renal Disease

Nephron Clin Pract, Vol. 97, Iss. 2, 2004-11 ,pp. : c67-c72

Karger

Access to resources Recommend Favorite